Lisa S Parker

Contributions to Public Health

• I bring my experience in the ethical design and conduct of research to research collaborations, training grants, directing the University’s Research Ethics Consultation Service, and national bodies such as the National Advisory Council for Human Genome Research, the NHGRI Genomics and Society Working Group, and the Electronic Medical Records and Genomics (eMERGE) Network. My research ethics scholarship particularly focuses on genetic/genomic research, mental health research, and the return of research results and incidental findings.
  • Parker LS. Returning individual research results: What role should people’s preferences play? Minnesota Journal of Law, Science & Technology 2012: 13(2): 449-484.
  • Parker LS. Genetics and Genomics Research. Oxford Handbook of Research Ethics, Ed. D MacKay and A. Iltis, Oxford University Press, 2024. https://doi.org/10.1093/oxfordhb/9780190947750.013.31
• I am currently collaborating to develop a framework for evaluating research involving healthcare workers as subjects of research, a key ethical concern within a learning healthcare system. This project draws on my previous scholarship on community engaged mental health research, as well as recent collaborations in neuro-rehabilitation and neurological research.
  • Degenholtz HD, Parker LS, Reynolds CF. Trial design and informed consent for a clinic-based study with a treatment as usual control arm. Ethics and Behavior 2002; 12:43-62. PMID: 12171082
  • Alreja A, Ward MJ, Ma Q, Russ BE, Bickel A, Van Wouwe NC, González-Martínez JA, Neimat JS, Abel TJ, Bagić A, Parker LS, Richardson RM, Schroeder CE, Morency L, Ghuman AS, A new paradigm for investigating real-world social behavior and its neural underpinnings, Behavior Research Methods, 25 July 2022, doi: https://doi.org/10.3758/s13428-022-01882-9
• I serve as the Associate Director for Bioethics of Pitt’s Institute for Precision Medicine and have collaborated with colleagues in the School of Pharmacy on the Test2Learn pharmacogenomics educational program. My scholarship assesses the claims and potential benefit of precision medicine and “precision public health,” the effects of the “genomic turn” in biomedical research on disparities in health and healthcare, and the use of categories of race and ethnicity in genetic/genomic research.
  • Parker LS. Ethical Considerations in Precision Medicine. The Era of Precision Medicine, Ed. Bydon M. Elsevier, 2023, pp. 143-172.
  • Parker LS, Foster MW, Sharp RR. Genetic Research with Minority Populations, Race and Research: Perspectives on Minority Participation in Health Studies, 2nd edition, Ed. Beech B, Heitman E, 2024.
• In my teaching and research, I am interested in bioethics as a social practice and employ insights from feminist theory to examine issues and practices in bioethics and healthcare.
  • Parker LS. Ethical Expertise, Maternal Thinking, and the Work of Clinical Ethicists. Ethics Expertise: History, Contemporary Perspectives, and Applications. Ed. LM Rasmussen. Philosophy and Medicine Book Series, Dordrecht, The Netherlands: Springer, 2005, pp. 165-180.
  • Parker LS. Bioethics in the current climate, Perspectives in Biology and Medicine, 2022, 65(4):680-693. doi: 10.1353/pbm.2022.0060
• As a philosopher-bioethicist, I employ normative and conceptual methods and draw on ethical and political theory to analyze issues arising in healthcare, public health, genomic research, and other research areas. Two papers articulate those methods and illustrate the use of a theory of justice to address issues in genetics, genomics, and gene therapy.
  • Parker LS, Sankar PL, Boyer J, McEwan J, Kaufman D. Normative and Conceptual ELSI Research: What it is, and why it’s important. Genetics in Medicine 2019, 21:505–509. PMID:29970926 DOI: 10.1038/s41436-018-0065-x
  • Parker LS. In sport and social justice, is genetic enhancement a game changer? Health Care Analysis 2012; 20(4):328-46 doi: 10.1007/s10728-012-0226-z. PMID: 22983765
• Currently, I am exploring points of conceptual and ethical synergy across genomic research, predictive analytics, and research employing large language models.